Search - tctmd.com

Displaying 321 - 340 of 465

Sort: Relevancy | Date

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

News Industry News

Tryton Medical Announces Completion of Enrollment in the EXTENDED ACCESS Registry for its Tryton Side Branch Stent

August 03, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Daily News

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

Todd Neale

July 23, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Industry News

Thoratec Receives CE Mark Approval For HeartMate PHP™

July 13, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Industry News

Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon

June 10, 2015

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Industry News

STENTYS: First Clinical Experience with Xposition shows 100% implantation success, Confirms Ease of Use

May 20, 2015

News Industry News

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

May 20, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

News Industry News

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

May 19, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

Advertisement

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

Tryton Medical Announces Completion of Enrollment in the EXTENDED ACCESS Registry for its Tryton Side Branch Stent

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

Registry Provides Reassurance About Rotational Atherectomy Pre-PCI

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

Thoratec Receives CE Mark Approval For HeartMate PHP™

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Trials Explore the Potential of Biodegradable-Polymer Stents

STENTYS: First Clinical Experience with Xposition shows 100% implantation success, Confirms Ease of Use

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content